“orbimed-advisors” Archives

in
Entry Author Date Location
SpringWorks Spins Out of Pfizer With $103M to Give Shelved Drugs New Life 09/25/17 New York
Bio Roundup: $1B Deals, Data Bumps, Acorda’s Lumps, Generic OKs & More 08/11/17 National
For Parkinson’s, Two New Drugs Coming As Prevail Gets Started in NY 08/09/17 New York
Not Resting on Hemophilia Biz, Bioverativ Pays $400M For True North 05/23/17 Boston
Gates Foundation Leads $45.5M Round for Gerngross’s Biotech Arsanis 04/26/17 Boston
Ex-Dendreon CEO, Gold, Returns to Wall Street as Alpine, Nivalis Merge 04/18/17 Seattle
Aiming At P53, Cancer’s Hard Target, PMV Pharma Raises $74M 02/22/17 New York
Cleave Bio Gets $37M From Celgene, Others For Clinical Push 08/08/16 San Francisco
Audentes Prices $75M IPO As Gene Therapy Eyes First U.S. Approval 07/20/16 San Francisco
Retooled Selecta Bio Takes Crossover Cash to IPO Queue 05/24/16 Boston
West Coast Biotech Roundup: Gilead, Adicet, Otonomy, Fate & More 01/29/16 San Diego
Adicet Joins the Immunotherapy Fray With $51M and Mystery Cells 01/27/16 San Francisco
Exosome Diagnostics Closes $60M Series B for Liquid Biopsy Test 01/07/16 Boston
With $100M, Guardant Health to Expand Reach of Blood Test for Cancer 01/07/16 San Francisco
Bristol-Myers to Add Cardioxyl’s Heart Failure Drug With $300M Deal 11/02/15 Raleigh Durham
Alector Raises $32M For Immune-Based Neuro Drug Development 09/16/15 San Francisco
Avitide Gets $7.6M More to Purify Complex Biologics 08/06/15 Boston
Gene Therapy Upstart Dimension Nabs $65M From “Crossover” Backers 04/21/15 Boston
Pop That Bubble: 5 Reasons Biotech Needs A Different Metaphor 04/14/15 National
West Coast Biotech Roundup: Juno, Tekmira, True North, aTyr & More 04/10/15 Seattle
With $35M Infusion, True North Moves Rare Disease Drug Into Clinic 04/07/15 San Francisco
Prenatal Screener Natera Grabs $55M, Considers Cancer Test 04/06/15 San Francisco
Tricida Grabs $30M Series B for Chronic Kidney Disease Treatment 03/04/15 San Francisco
East Coast Biotech Roundup: Raze, Retrophin, Alnylam, & More 10/16/14 Boston
Selecta, Sharpening Focus, Gets $20M More to Make Biologics Safer 10/15/14 Boston
East Coast Biotech Roundup: Biogen, Civitas, Rhythm, Alkermes, & More 08/29/14 Boston
MoneyTree Reports $121M in MI Venture Deals Last Quarter 07/22/14 Detroit Ann Arbor
How a Little Serendipity Led Acceleron to a Crippling Blood Disease 07/17/14 Boston
Who Needs Biotech VCs, Anyway? 07/15/14 San Francisco
West Coast Biotech Roundup: Seragon, Ambrx, Pregenen, and More 07/03/14 San Diego
Page 1 of 6 next page »